Filing Details
- Accession Number:
- 0001079973-18-000078
- Form Type:
- 13G Filing
- Publication Date:
- 2018-02-02 16:35:29
- Filed By:
- Ibex Investors Llc
- Company:
- Biondvax Pharmaceuticals Ltd.
- Filing Date:
- 2018-02-02
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| IBEX INVESTORS | 14,360,000 | 0 | 14,360,000 | 0 | 14,360,000 | 5.5% |
| JUSTIN B. BORUS | 14,360,000 | 0 | 14,360,000 | 0 | 14,360,000 | 5.5% |
| IBEX ISRAEL FUND LLLP | 14,360,000 | 0 | 14,360,000 | 0 | 14,360,000 | 5.5% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(AMENDMENT NO. 1)
Under the Securities Exchange Act of 1934
| BIONDVAX PHARMACEUTICALS LTD. |
| (Name of Issuer) |
| Ordinary Shares |
| (Title of Class of Securities) |
| 09073Q105 |
| (CUSIP Number) |
| December 31, 2017 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| 1 | NAMES OF REPORTING PERSONS | | | ||
| IBEX INVESTORS LLC | | | |||
| | | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | ||||
| (a)☐ | |||||
| (b)☒ | | | |||
| 3 | SEC USE ONLY | | | ||
| | | | |||
| | | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | ||
| Colorado | | | |||
| | | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER | | | |
| 14,360,000* | | | |||
| | | ||||
| 6 | SHARED VOTING POWER | | | ||
| 0 | | | |||
| | | ||||
| 7 | SOLE DISPOSITIVE POWER | | | ||
| 14,360,000* | | | |||
| | | ||||
| 8 | SHARED DISPOSITIVE POWER | | | ||
| 0 | | | |||
| | | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | ||
| 14,360,000* | | | |||
| | | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | | | ||
| ☐ | | | |||
| | | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | ||
| 5.5% | | | |||
| | | ||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | | | ||
| IA | | | |||
| | | ||||
* Reporting Persons own 359,000 American Depository Shares representing 14,360,000 Ordinary Shares.
| 1 | NAMES OF REPORTING PERSONS | | | ||
| JUSTIN B. BORUS | | | |||
| | | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | ||||
| (a)☐ | |||||
| (b)☒ | | | |||
| 3 | SEC USE ONLY | | | ||
| | | | |||
| | | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | ||
| United States | | | |||
| | | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER | | | |
| 14,360,000* | | | |||
| | | ||||
| 6 | SHARED VOTING POWER | | | ||
| 0 | | | |||
| | | ||||
| 7 | SOLE DISPOSITIVE POWER | | | ||
| 14,360,000* | | | |||
| | | ||||
| 8 | SHARED DISPOSITIVE POWER | | | ||
| 0 | | | |||
| | | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | ||
| 14,360,000* | | | |||
| | | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | | | ||
| ☐ | | | |||
| | | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | ||
| 5.5% | | | |||
| | | ||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | | | ||
| IN/HC | | | |||
| | | ||||
* Reporting Persons own 359,000 American Depository Shares representing 14,360,000 Ordinary Shares.
| 1 | NAMES OF REPORTING PERSONS | | | ||
| IBEX ISRAEL FUND LLLP | | | |||
| | | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | ||||
| (a)☐ | |||||
| (b)☒ | | | |||
| 3 | SEC USE ONLY | | | ||
| | | | |||
| | | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | ||
| Delaware | | | |||
| | | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER | | | |
| 14,360,000* | | | |||
| | | ||||
| 6 | SHARED VOTING POWER | | | ||
| 0 | | | |||
| | | ||||
| 7 | SOLE DISPOSITIVE POWER | | | ||
| 14,360,000* | | | |||
| | | ||||
| 8 | SHARED DISPOSITIVE POWER | | | ||
| 0 | | | |||
| | | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | ||
| 14,360,000* | | | |||
| | | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | | | ||
| ☐ | | | |||
| | | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | ||
| 5.5% | | | |||
| | | ||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | | | ||
| PN | | | |||
| | | ||||
* Reporting Persons own 359,000 American Depository Shares representing 14,360,000 Ordinary Shares.
| Item 1. | |
(a) Name of Issuer:
BiondVax Pharmaceuticals Ltd. (the "Issuer")
(b) Address of Issuer's Principal Executive Office:
14 Einstein St.
Ness Ziona
Israel 74036
| Item 2. | |
(a) Name of Person Filing:
Ibex Investors LLC ("Ibex")
Justin B. Borus
Ibex Israel Fund LLLP ("Ibex Israel" and together with Ibex and Mr. Borus, the "Reporting Persons")
(b) Address of Principal Business Office or, if none, Residence:
The business address of each of the Reporting Persons is c/o Ibex Investors LLC, 3200 Cherry Creek South Drive, Suite 670, Denver, Colorado 80209.
(c) Citizenship:
Reference is made to Item 4 of pages 2–4 of this Schedule 13G (this "Schedule"), which Items are incorporated by reference herein.
(d) Title of Class of Securities:
Ordinary Shares, NIS 0.0000001 par value per share
(e) CUSIP Number:
09073Q105
| Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| | ☐ | (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
| | ☐ | (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
| | ☐ | (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
| | ☐ | (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8). |
| | ý | (e) | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
| | ☐ | (f) | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
| | ý | (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); |
| | ☐ | (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| | ☐ | (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
| | ☐ | (j) | Group, in accordance with §240.13d-1(b)(1)(ii)(J). |
| Item 4. | Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. |
Reference is hereby made to Items 5-9 and 11 of pages 2 - 4 of this Schedule, which Items are incorporated by reference herein. Reporting Persons own 359,000 American Depository Shares representing 14,360,000 Ordinary Shares.
Ibex is the investment adviser of Ibex Israel and consequently may be deemed to have voting control and investment discretion over the securities owned by Ibex Israel. Justin B. Borus is the manager of Ibex. As a result, Mr. Borus may be deemed to be the beneficial owner of any shares deemed to be beneficially owned by Ibex. The foregoing should not be construed in and of itself as an admission by Ibex or Mr. Borus as to beneficial ownership of the shares owned by Ibex Israel. Each of Ibex and Mr. Borus disclaims beneficial ownership of the securities set forth in this Schedule 13G except to the extent of its or his pecuniary interests therein.
The calculation of percentage of beneficial ownership in Item 11 of pages 2-4 was calculated based on 261,419,599 Ordinary Shares outstanding as reported by the Issuer in its Prospectus Supplement filed with the Securities and Exchange Commission on September 15, 2017.
| Item 5. | Ownership of Five Percent or Less of a Class. |
Not Applicable.
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable.
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. |
Not Applicable.
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable.
| Item 9. | Notice of Dissolution of Group. |
Not Applicable.
| Item 10. | Certification. |
By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
Signature
After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
Dated: February 2, 2018
| IBEX INVESTORS LLC |
| By: /s/ Justin B. Borus |
| Name: Justin B. Borus Title: Manager |
| /s/ Justin B. Borus |
| Justin B. Borus |
| IBEX ISRAEL FUND LLLP By: IBEX GP LLC its general partner |
| By: /s/ Justin B. Borus |
| Name: Justin B. Borus Title: Manager |
EXHIBIT INDEX
Exhibit A – Joint Filing Undertaking
EXHIBIT A
JOINT FILING UNDERTAKING
The undersigned, being authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule, as it may be amended, jointly on behalf of each of such parties.
Dated: February 2, 2018
| IBEX INVESTORS LLC |
| By: /s/ Justin B. Borus |
| Name: Justin B. Borus Title: Manager |
| /s/ Justin B. Borus |
| Justin B. Borus |
| IBEX ISRAEL FUND LLLP By: IBEX GP LLC its general partner |
| By: /s/ Justin B. Borus |
| Name: Justin B. Borus Title: Manager |